Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-22

Clinical Trial Update: Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals [Phase 3]

View source ↗

Summary

Phase 3 trial assessing buprenorphine stabilization and induction onto Vivitrol for heroin dependence; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivitrol (naltrexone extended-release injectable)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Heroin Dependence | Phase 3 | Status: TERMINATED | Results posted: 2022-12-22